2.A.6.2.15 Multidrug efflux pump, MexCD-OprJ (exports β-lactams, fluoroquinolones, tetracycline, macrolides, chloramphenicol, biocides, including levofloxacin, carbenicillin, aztreonam, ceftazidime, cefepime, cefoperazone, piperacillin, erythromycin, azithromycin, chloramphenicol, etc.; Mao et al., 2002). Functions with MexC (MFP) and OprJ (OMF) as indicated above (Mao et al., 2002; Poole, 2008; Lorusso et al. 2022). MexCD-OprJ is one of four primary drug exporters in P. aeruginosa (Lorusso et al. 2022). Collateral sensitivity (CS) is an evolutionary trade-off traditionally
linked to the mutational acquisition of antibiotic resistance (AR) (Hernando-Amado et al. 2023).
However, AR can be temporally induced. Mutational
acquisition of ciprofloxacin resistance leads to robust CS to tobramycin
in pre-existing antibiotic-resistant mutants of Pseudomonas aeruginosa.
Further, the strength of this phenotype is higher when nfxB mutants,
over-producing the efflux pump MexCD-OprJ, are selected. Hernando-Amado et al. 2023 induced
transient nfxB-mediated ciprofloxacin resistance by using the
antiseptic dequalinium chloride. Notably, non-inherited induction of AR
renders transient tobramycin CS in the analyzed antibiotic-resistant
mutants and clinical isolates, including tobramycin-resistant isolates.
Further, by combining tobramycin with dequalinium chloride we drive
these strains to extinction. Our results support that transient CS could
allow the design of new evolutionary strategies to tackle
antibiotic-resistant infections, avoiding the acquisition of AR
mutations on which inherited CS depends (Hernando-Amado et al. 2023). The type of quinolone resistance mechanism is related to the frequency of
MDRP and the risk of MDRP incidence is highly dependent on the
order of exposure to gentamicin and ciprofloxacin (Yasuda et al. 2023).
|
Accession Number: | Q51397 |
Protein Name: | Outer membrane protein OprJ |
Length: | 479 |
Molecular Weight: | 51958.00 |
Species: | Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) [208964] |
Number of TMSs: | 1 |
Location1 / Topology2 / Orientation3: |
Cell outer membrane1 / Lipid-anchor2 |
Substrate |
macrolide, fluoroquinolone antibiotic, levofloxacin, ciprofloxacin, chloramphenicol, beta-lactam, cefepime, aztreonam, tetracycline, tobramycin, erythromycin A, carbenicillin, ceftazidime, piperacillin, cefoperazone, azithromycin |
---|
1: MRKPAFGVSA LLIALTLGAC SMAPTYERPA APVADSWSGA AAQRQGAAID TLDWKSFIVD
61: AELRRLVDMA LDNNRSLRQT LLDIEAARAQ YRIQRADRVP GLNAAATGNR QRQPADLSAG
121: NRSEVASSYQ VGLALPEYEL DLFGRVKSLT DAALQQYLAS EEAARAARIA LVAEVSQAYL
181: SYDGALRRLA LTRQTLVSRE YSFALIDQRR AAGAATALDY QEALGLVEQA RAEQERNLRQ
241: KQQAFNALVL LLGSDDAAQA IPRSPGQRPK LLQDIAPGTP SELIERRPDI LAAEHRLRAR
301: NADIGAARAA FFPRISLTGS FGTSSAEMSG LFDGGSRSWS FLPTLTLPIF DGGRNRANLS
361: LAEARKDSAV AAYEGTIQTA FREVADALAA SDTLRREEKA LRALANSSNE ALKLAKARYE
421: SGVDNHLRYL DAQRSSFLNE IAFIDGSTQR QIALVDLFRA LGGGWDEGRS LVVHRGGRS